Trial Comparing the Incidence of Steal Syndrome in the Two Types of anTEcubitaL Fossa Arteriovenous fistuLa AVF
NCT ID: NCT02297451
Last Updated: 2020-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
79 participants
INTERVENTIONAL
2011-02-28
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Arteriovenous fistula (AVF) is a form of vascular access for haemodialysis. An AVF is normally created at the level of the wrist, but occasionally it is created in the elbow when there is no suitable vessel in the forearm. The most common type of elbow (antecubital) fistula (AFF) is a brachiocephalic fistula, which carries significantly higher risk of steal syndrome (AVF-associated hand ischaemia) than wrist fistulas. More recently, AFF using proximal radial or ulnar artery as inflow has been described and shown to have a lower rate of Steal syndrome than brachiocephalic fistula. This study aims to investigate the incidence of steal syndrome between AFF using brachial artery and that using the proximal radial/ulnar artery as inflow.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients
NCT02874391
Vein Histology in Arteriovenous Fistulas and Its Effect on Fistula Surgery Success
NCT01099189
Cohort Study on A Following-up System of Native Arteriovenous Fistulae
NCT02880761
Randomized Fistula Study
NCT00808561
Comparison of Brachial Wrist Index Before and After Implantation of Arteriovenous Fistulas, Based on Brachial Artery
NCT06365489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Steal syndrome relates to hand ischaemia associated with AVF creation, and is a major risk of AVF formation. The symptoms of steal syndrome ranges from cold extremities, numbness, hand claudication (pain after exercise), to rest pain and tissue loss. Steal syndrome can also be measured by Digital Brachial Pressure Index. Severe steal syndrome is debilitating, and limb-threatening, and requires surgical revision or ligation of the AVF. This leads to additional surgical risks and loss of dialysis vascular access.
Diabetes and the types of AVF have been found to be independent risk factors for developing steal syndrome following AVF creation1. The highest risk is seen in patients with a proximal AVF i.e. BCF/BBF; up to 50% of patients in some studies, compared to 5-8% in all upper limb AVFs.
An alternative technique that may reduce risk of steal in this group of patients is to anastomose the vein to the radial artery or ulnar artery, distal to the brachial artery bifurcation. This technique, theoretically, will only 'steal' blood from one artery e.g. radial artery if the anastomosis is created on the proximal radial artery so blood flow can therefore be maintained by the ulnar arterial system.
Recent studies have suggested that using the proximal radial or ulnar artery reduced the risk of steal to as low as 0% to 3%. The type of arterial inflow to an AFF is therefore a potentially significant factor in causing steal syndrome. There is, however, no current randomised controlled trial to prove this hypothesis.
The definition of steal syndrome varies greatly in the literature. Some studies have defined steal syndrome as the presence of mild symptoms such as cold hand, while the others reported steal syndrome when it was severe enough to require surgical intervention. This has led to the huge variations in the incidence of steal syndrome being reported and has made comparison difficult between studies. A few scoring systems to describe the severity of steal syndrome have been suggested in previous studies, but none of them has been widely used.
In this study, the difference in the severity of steal between the two intervention groups will be investigated. This will be done using the Hoek score, which was originally used by Hoek et al in 2006 to report steal syndrome associated with the AVFs created in their centre. There was, however, no comparison of scores among the different types of AVF.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Brachial artery inflow
Elbow fistula created with brachial artery as inflow (ie. either brachiocephalic or brachiobasilic fistulas)
No interventions assigned to this group
Proximal radial/ulnar artery as inflow
Elbow fistula created with either proximal radial or ulnar artery as inflow
Proximal radial/ulnar artery as inflow
Proximal radial/ulnar artery used as inflow
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Proximal radial/ulnar artery as inflow
Proximal radial/ulnar artery used as inflow
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cambridge University Hospitals NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aaron Goh
Clinical Research Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gavin Pettigrew, MD, FRCS
Role: PRINCIPAL_INVESTIGATOR
University of Cambridge
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Addenbrooke's Hospital
Cambridge, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10/H0308/90
Identifier Type: OTHER
Identifier Source: secondary_id
A091982
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.